Stemming bone loss by suppressing apoptosis.
作者信息
Hock J M
机构信息
Lilly Research Labs, Indianapolis, Indiana 46285, USA.
出版信息
J Clin Invest. 1999 Aug;104(4):371-3. doi: 10.1172/JCI7991.
Abstract
摘要
相似文献
1
Stemming bone loss by suppressing apoptosis.
J Clin Invest. 1999 Aug;104(4):371-3. doi: 10.1172/JCI7991.
2
Parathyroid hormone and periosteal bone expansion.
J Bone Miner Res. 2002 Oct;17(10):1741-3. doi: 10.1359/jbmr.2002.17.10.1741.
3
Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans.
Scand J Clin Lab Invest. 2012 Feb;72(1):14-22. doi: 10.3109/00365513.2011.624631. Epub 2011 Nov 16.
4
[Perspective for development of parathyroid hormone and related compounds as therapeutic agents for osteoporosis].
Nihon Rinsho. 2005 Oct;63 Suppl 10:367-71.
5
[PTH injection for the treatment of osteoporosis].
Nihon Rinsho. 2002 Mar;60 Suppl 3:544-51.
6
[Acceleration of bone formation].
Nihon Rinsho. 2005 Oct;63 Suppl 10:317-20.
7
Anabolic effects of intermittent PTH on osteoblasts.
Curr Mol Pharmacol. 2012 Jun;5(2):127-34.
8
PTH increases jaw mineral density in a rabbit model of osteoporosis.
J Dent Res. 2010 Apr;89(4):360-5. doi: 10.1177/0022034510363082. Epub 2010 Feb 22.
9
Parathyroid hormone: a double-edged sword for bone metabolism.
Trends Endocrinol Metab. 2004 Mar;15(2):60-5. doi: 10.1016/j.tem.2004.01.006.
10
Evaluation of pharmaceuticals with a novel 50-hour animal model of bone loss.
J Bone Miner Res. 2009 Jul;24(7):1194-205. doi: 10.1359/jbmr.090217.
引用本文的文献
1
Anabolic agents and bone quality.
Clin Orthop Relat Res. 2011 Aug;469(8):2215-24. doi: 10.1007/s11999-010-1722-9.
2
Vascular endothelial growth factor regulates osteoblast survival - evidence for an autocrine feedback mechanism.
J Orthop Surg Res. 2009 Jun 16;4:19. doi: 10.1186/1749-799X-4-19.
3
PTH and PTHrP effects on the skeleton.
Rev Endocr Metab Disord. 2000 Nov;1(4):331-41. doi: 10.1023/a:1026526703898.
4
Pathogenesis of postmenopausal osteoporosis.
Rev Endocr Metab Disord. 2001 Jan;2(1):5-12. doi: 10.1023/a:1010074422268.
本文引用的文献
1
Cell division in endochondral ossification. A study of cell proliferation in rat bones by the method of tritiated thymidine autoradiography.
J Bone Joint Surg Br. 1960 Nov;42B:824-39.
2
Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys.
J Clin Endocrinol Metab. 1999 Oct;84(10):3757-63. doi: 10.1210/jcem.84.10.6039.
3
Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone.
J Clin Invest. 1999 Aug;104(4):439-46. doi: 10.1172/JCI6610.
4
Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation.
Mol Cell Biol. 1999 Jun;19(6):4431-42. doi: 10.1128/MCB.19.6.4431.
5
Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits.
J Bone Miner Res. 1999 Apr;14(4):536-45. doi: 10.1359/jbmr.1999.14.4.536.
6
Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice.
J Clin Invest. 1999 Feb;103(4):517-24. doi: 10.1172/JCI5481.
7
Enhanced osteoblast development after continuous infusion of hPTH(1-84) in the rat.
Bone. 1999 Feb;24(2):89-94. doi: 10.1016/s8756-3282(98)00170-7.
8
Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.
J Clin Invest. 1998 Oct 15;102(8):1627-33. doi: 10.1172/JCI3914.
9
Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized rats.
Endocrinology. 1998 Oct;139(10):4086-91. doi: 10.1210/endo.139.10.6227.
10
Intermittent administration of parathyroid hormone (1-34) stimulates matrix metalloproteinase-9 (MMP-9) expression in rat long bone.
J Cell Biochem. 1998 Sep 1;70(3):391-401.
Zotero 插件